These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19240076)

  • 1. Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria.
    Citron DM; Warren YA; Tyrrell KL; Merriam V; Goldstein EJ
    J Antimicrob Chemother; 2009 May; 63(5):972-6. PubMed ID: 19240076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.
    Critchley IA; Green LS; Young CL; Bullard JM; Evans RJ; Price M; Jarvis TC; Guiles JW; Janjic N; Ochsner UA
    J Antimicrob Chemother; 2009 May; 63(5):954-63. PubMed ID: 19258353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
    Ochsner UA; Bell SJ; O'Leary AL; Hoang T; Stone KC; Young CL; Critchley IA; Janjic N
    J Antimicrob Chemother; 2009 May; 63(5):964-71. PubMed ID: 19251726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobacilli.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT; Bryskier A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):408-13. PubMed ID: 15616322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of imipenem against gram-positive anaerobic bacteria.
    Dubreuil L; Devos J; Romond C
    Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.
    Tyrrell KL; Citron DM; Warren YA; Fernandez HT; Merriam CV; Goldstein EJ
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2728-31. PubMed ID: 16870765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of obligate anaerobes in infections in hospitalized patients and therapeutic options].
    Wróblewska M; Rokosz A; Sawicka-Grzelak A; Kot K; Luczak M
    Med Dosw Mikrobiol; 2005; 57(2):199-208. PubMed ID: 16134392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species.
    Credito KL; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4430-4. PubMed ID: 15504874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Calvet L
    Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.
    Finegold SM; John SS; Vu AW; Li CM; Molitoris D; Song Y; Liu C; Wexler HM
    Anaerobe; 2004 Aug; 10(4):205-11. PubMed ID: 16701520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
    Wexler HM; Engel AE; Glass D; Li C
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4413-7. PubMed ID: 16189137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antagonistic activity of Lactobacillus bacteria strains against anaerobic gastrointestinal tract pathogens (Helicobacter pylori, Campylobacter coli, Campylobacter jejuni, Clostridium difficile)].
    Strus M; Pakosz K; Gościniak H; Przondo-Mordarska A; Rozynek E; Pituch H; Meisel-Mikołajczyk F; Heczko PB
    Med Dosw Mikrobiol; 2001; 53(2):133-42. PubMed ID: 11757422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.
    Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez HT
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification and susceptibility to antimicrobial agents of strictly anaerobic bacteria isolated from hospitalized patients].
    Kot K; Rokosz A; Sawicka-Grzelak A; łuczak M
    Med Dosw Mikrobiol; 2002; 54(3):233-41. PubMed ID: 12632658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of tigecycline against strains isolated from diabetic foot ulcers.
    Sotto A; Bouziges N; Jourdan N; Richard JL; Lavigne JP
    Pathol Biol (Paris); 2007 Nov; 55(8-9):398-406. PubMed ID: 17905534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.
    Goldstein EJ; Citron DM; Vaidya SA; Warren YA; Tyrrell KL; Vreni Merriam C; Fernandez H
    Anaerobe; 2006 Apr; 12(2):63-6. PubMed ID: 16701615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.